Top Five Global Home Healthcare Device Companies: Performance, Strategies, and Competitive Analysis, November 2012
The global home healthcare device industry has experienced good growth over the last five years and is expected to reach approximately US $29 billion in 2017 with a CAGR of 3% over the next five years.
Lucintel, a leading global management consulting and market research firm, has conducted a competitive analysis of the global home health care device companies and presents its findings in “Top Five Global Home Healthcare Device Companies: Performance, Strategies, and Competitive Analysis.” The report provides detailed insight into the performance of the top five home health care device companies across the world. The analysis highlights the companies that are performing the best among the peer group, and in which areas, and therefore clarifies leading performance standards and the strengths and weaknesses of the companies covered.
The home healthcare device industry comprises manufacturers of blood pressure monitors, glucose monitors, diabetics control devices, wheelchairs, walking aids, oxygen inhalers, thermometers and other devices. The industry is consolidated. In this study, Lucintel thoroughly profiles the following five companies with detailed competitive assessments:
This study provides industry leaders with a competitive benchmarking of the world’s top five home healthcare device companies. The study provides up-to-date information on the market share, profit margins, capabilities, and strategies of the leaders. The report helps current suppliers realistically assess their industry standing vis-a-vis leading competitors. It is designed to provide executives with strategically significant competitor information, data analysis, and insight, critical to the development and implementation of effective marketing and sales plans.
This report will save hundreds of hours of your own personal research time and will significantly benefit you in expanding your business opportunities in global home healthcare device companies. In today’s chaotic economy, you need every advantage that you can find to keep ahead in your business
Lucintel, a leading global management consulting and market research firm, has conducted a competitive analysis of the global home health care device companies and presents its findings in “Top Five Global Home Healthcare Device Companies: Performance, Strategies, and Competitive Analysis.” The report provides detailed insight into the performance of the top five home health care device companies across the world. The analysis highlights the companies that are performing the best among the peer group, and in which areas, and therefore clarifies leading performance standards and the strengths and weaknesses of the companies covered.
The home healthcare device industry comprises manufacturers of blood pressure monitors, glucose monitors, diabetics control devices, wheelchairs, walking aids, oxygen inhalers, thermometers and other devices. The industry is consolidated. In this study, Lucintel thoroughly profiles the following five companies with detailed competitive assessments:
- Abbott Laboratories
- Invacare Corporation
- Johnson & Johnson
- 3M
- Philips
This study provides industry leaders with a competitive benchmarking of the world’s top five home healthcare device companies. The study provides up-to-date information on the market share, profit margins, capabilities, and strategies of the leaders. The report helps current suppliers realistically assess their industry standing vis-a-vis leading competitors. It is designed to provide executives with strategically significant competitor information, data analysis, and insight, critical to the development and implementation of effective marketing and sales plans.
This report will save hundreds of hours of your own personal research time and will significantly benefit you in expanding your business opportunities in global home healthcare device companies. In today’s chaotic economy, you need every advantage that you can find to keep ahead in your business
1. EXECUTIVE SUMMARY
2. MARKET DEFINITION AND SCOPE
3. MARKET OPPORTUNITY
4. COMPETITIVE BENCHMARKING (FINANCIAL AND MARKET)
Company Profile on Following Parameters
Company Overview
Benchmarking (Financial & Market)
SWOT Analysis
Product Positioning
Marketing Strategy and Tactics
Corporate Strategy
5. COMPANY PROFILE ON ABBOTT LABORATORIES
6. COMPANY PROFILE ON INVACARE CORPORATION
7. COMPANY PROFILE ON JOHNSON & JOHNSON
8. COMPANY PROFILE ON 3M
9. COMPANY PROFILE ON PHILIPS
2. MARKET DEFINITION AND SCOPE
3. MARKET OPPORTUNITY
4. COMPETITIVE BENCHMARKING (FINANCIAL AND MARKET)
Company Profile on Following Parameters
Company Overview
Benchmarking (Financial & Market)
SWOT Analysis
Product Positioning
Marketing Strategy and Tactics
Corporate Strategy
5. COMPANY PROFILE ON ABBOTT LABORATORIES
6. COMPANY PROFILE ON INVACARE CORPORATION
7. COMPANY PROFILE ON JOHNSON & JOHNSON
8. COMPANY PROFILE ON 3M
9. COMPANY PROFILE ON PHILIPS
LIST OF FIGURES AND CHARTS
CHAPTER 3. Market Opportunity
Figure 3.1: Supply chain for pesticide market
Figure 3.2: Global pesticide industry annual trend 2006-2011 (US $B)
Figure 3.3: Global pesticide industry regional trend 2006-2011 (US $B)
Figure 3.4: Global pesticide industry regional trend 2006-2011 (%)
Figure 3.5: Global pesticide industry segment trend 2006-2011 (US $B)
Figure 3.6: Global pesticide industry segment trend 2006-2011 (%)
Figure 3.7: Global pesticide industry opportunity by region
Figure 3.8: Global pesticide industry opportunity by segment
CHAPTER 4.Competitive Benchmarking (Financial and Market)
Figure 4.1: Top five pesticide companies – financial benchmarking
Figure 4.2: Global top five pesticide companies gross profit and net profit analysis – 2011
Figure 4.3: Financial analysis – growth leadership quadrant (2011)
Figure 4.4: Market share of top players 2006
Figure 4.5: Market share of top players 2011
Figure 4.6: 2006 Market share analysis
Figure 4.7: 2011 Market share analysis
Figure 4.8: Global market share analysis 2011
Figure 4.9: Global market fragmentation 2011
Figure 4.10: Market value North America (US $B)
Figure 4.11: Market value Europe (US $B)
Figure 4.12: Market value Asia Pacific (US $B)
Figure 4.13: Market value Row: (US $B)
Figure 4.14: Regional revenue evaluation 2011(US $M)
Figure 4.15: Regional revenue evaluation 2011(%)
Figure 4.16: North American revenue trend for top players 2007-2011 (US $B)
Figure 4.17: Europe revenue trend for top players 2007-2011 (US $B)
Figure 4.18: Asia Pacific revenue trend for top players 2007-2011 (US $B)
Figure 4.19: Row revenue trend for top players 2007-2011 (US $B)
Figure 4.20: Lucintel triad - top five major players
CHAPTER 5. Company Profile of Abbott Laboratories
Figure 5.1: Abbott Laboratories revenue by business structure 2011
Figure 5.2: Lucintel Triad – Abbott Laboratories
Figure 5.3: Financial benchmarking Abbott Laboratories against top three and top five industry players’ average
Figure 5.4: Financial benchmarking of Abbott Laboratories against Top Five best
Figure 5.5: Global industry revenue trend Vs Abbott Laboratories (2007-2011) in US $B
Figure 5.6: Global market share trend for Abbott Laboratories (2007-2011) in (%)
Figure 5.7: North American industry revenue trend Vs Abbott Laboratories 2007-2011 in (US $B)
Figure 5.8: European industry revenue trend Vs Abbott Laboratories 2007-2011 in (US $B)
Figure 5.9: APAC industry revenue trend Vs Abbott Laboratories 2007-2011 in (US $B)
Figure 5.10: ROW industry revenue trend Vs Abbott Laboratories 2007-2011 in (US $B)
Figure 5.11: North American market share trend Vs Abbott Laboratories 2007-2011 in (%)
Figure 5.12: European market share trend Vs Abbott Laboratories 2007-2011 in (%)
Figure 5.13: APAC market share trend Vs Abbott Laboratories 2007-2011 in (%)
Figure 5.14: ROW market share trend Vs Abbott Laboratories 2007-2011 in (%)
Figure 5.15: Abbott Laboratories productivity: 2007-2011 in (US $B)
Figure 5.16: Abbott Laboratories fixed asset value: 2007-2011 in (US $B)
Figure 5.17: Strategic execution
CHAPTER 6. Company Profile of Invacare Corporation
Figure 6.1: Invacare Corporation. revenue by business structure 2011
Figure 6.2: Lucintel triad - Invacare Corporation
Figure 6.3: Financial benchmarking of Invacare Corporation. against top three and top five industry players’ average
Figure 6.4: Financial benchmarking of Invacare Corporation against Top five best
Figure 6.5: Global industry revenue trend Vs Invacare Corporation (2007-2011) in (US $B)
Figure 6.6: Global market share trend for Invacare Corporation. (2007-2011) in (%)
Figure 6.7: North American industry revenue trend Vs Invacare Corporation (2007-2011 in (US $B)
Figure 6.8: European industry revenue trend Vs Invacare Corporation 2007-2011 in (US $B)
Figure 6.9: APAC industry revenue trend Vs Invacare Corporation 2007-2011 in (US $B)
Figure 6.10: ROW industry revenue trend Vs Invacare Corporation 2007-2011 in (US $B)
Figure 6.11: North American market share trend Vs Invacare Corporation 2007-2011 in (%)
Figure 6.12: European market share trend Vs Invacare Corporation 2007-2011 in (%)
Figure 6.13: APAC market share trend Vs Invacare Corporation 2007-2011 in (%)
Figure 6.14: ROW market share trend Vs Invacare Corporation 2007-2011 in (%)
Figure 6.15: Invacare Corporation productivity: 2007-2011 in (US $B)
Figure 6.16: Invacare Corporation fixed asset value: 2007-2011 in (US $B)
Figure 6.17: Strategic execution
CHAPTER 7. Company Profile of Johnson & Johnson
Figure 7.1: Johnson & Johnson revenue by business structure 2011
Figure 7.2: Lucintel triad – Johnson & Johnson
Figure 7.3: Financial benchmarking of Johnson & Johnson against top three and top five industry players’ average
Figure 7.4: Financial benchmarking of Johnson & Johnson against Top five best
Figure 7.5: Global industry revenue trend Vs Johnson & Johnson (2007-2011) in (US $B)
Figure 7.6: Global market share trend for Johnson & Johnson (2007-2011) in (%)
Figure 7.7: North American industry revenue trend Vs Johnson & Johnson (2007-2011) in (US $B)
Figure 7.8: European industry revenue trend Vs Johnson & Johnson (2007-2011) in (US $B)
Figure 7.9: APAC industry revenue trend Vs Johnson & Johnson (2007-2011) in (US $B)
Figure 7.10: ROW industry revenue trend Vs Johnson & Johnson (2007-2011) in (US $B)
Figure 7.11: North American market share trend Vs Johnson & Johnson (2007-2011) in (%)
Figure 7.12: European market share trend Vs Johnson & Johnson (2007-2011) in (%)
Figure 7.13: APAC market share trend Vs Johnson & Johnson (2007-2011) in (%)
Figure 7.14: ROW market share trend Vs Johnson & Johnson (2007-2011) in (%)
Figure 7.15: Johnson & Johnson productivity: 2007-2011 in (US $B)
Figure 7.16: Johnson & Johnson fixed asset value: 2007-2011 in (US $B)
Figure 7.17: Strategic execution
CHAPTER 8. Company Profile of 3M
Figure 8.1: 3M revenue by business structure 2011
Figure 8.2: Lucintel triad – 3M
Figure 8.3: Financial benchmarking of 3M against top three and top five industry players’ average
Figure 8.4: Financial benchmarking of3M against Top five best
Figure 8.5: Global industry revenue trend Vs 3M (2007-2011) in (US $B)
Figure 8.6: Global market share trend for3M (2007-2011) in (%)
Figure 8.7: North American industry revenue trend Vs 3M (2007-2011) in (US $B)
Figure 8.8: European industry revenue trend Vs 3M (2007-2011) in (US $B)
Figure 8.9: APAC industry revenue trend Vs 3M (2007-2011) in (US $B)
Figure 8.10: ROW industry revenue trend Vs3M (2007-2011) in (US $B)
Figure 8.11: North American market share trend Vs 3M (2007-2011) in (%)
Figure 8.12: European market share trend Vs 3M (2007-2011) in (%)
Figure 8.13: APAC market share trend Vs 3M. (2007-2011) in (%)
Figure 8.14: ROW market share trend Vs 3M (2007-2011) in (%)
Figure 8.15: 3M productivity: 2007-2011 in (US $B)
Figure 8.16: 3M fixed asset value: 2007-2011 in (US $B)
Figure 8.17: Strategic execution
CHAPTER 9. Company Profile of Philips
Figure 9.1: Philips revenue by business structure 2011
Figure 9.2: Lucintel triad – Philips
Figure 9.3: Financial benchmarking of Philips against top three and top five industry players’ average
Figure 9.4: Financial benchmarking of Philips against Top five best
Figure 9.5: Global industry revenue trend Vs Philips (2007-2011) in (US $B)
Figure 9.6: Global market share trend for Philips (2007-2011) in (%)
Figure 9.7: North American industry revenue trend Vs Philips (2007-2011) in (US $B)
Figure 9.8: European industry revenue trend Vs Philips (2007-2011) in (US $B)
Figure 9.9: APAC industry revenue trend Vs Philips (2007-2011) in (US $B)
Figure 9.10: ROW industry revenue trend Vs Philips (2007-2011) in (US $B)
Figure 9.11: North American market share trend Vs Philips (2007-2011) in (%)
Figure 9.12: European market share trend Vs Philips (2007-2011) in (%)
Figure 9.13: APAC market share trend Vs Philips (2007-2011) in (%)
Figure 9.14: ROW market share trend Vs Philips (2007-2011) in (%)
Figure 9.15: Philips productivity: 2007-2011 in (US $B)
Figure 9.16: Philips fixed asset value: 2006-2010 in (US $B)
Figure 9.17: Strategic execution
CHAPTER 3. Market Opportunity
Figure 3.1: Supply chain for pesticide market
Figure 3.2: Global pesticide industry annual trend 2006-2011 (US $B)
Figure 3.3: Global pesticide industry regional trend 2006-2011 (US $B)
Figure 3.4: Global pesticide industry regional trend 2006-2011 (%)
Figure 3.5: Global pesticide industry segment trend 2006-2011 (US $B)
Figure 3.6: Global pesticide industry segment trend 2006-2011 (%)
Figure 3.7: Global pesticide industry opportunity by region
Figure 3.8: Global pesticide industry opportunity by segment
CHAPTER 4.Competitive Benchmarking (Financial and Market)
Figure 4.1: Top five pesticide companies – financial benchmarking
Figure 4.2: Global top five pesticide companies gross profit and net profit analysis – 2011
Figure 4.3: Financial analysis – growth leadership quadrant (2011)
Figure 4.4: Market share of top players 2006
Figure 4.5: Market share of top players 2011
Figure 4.6: 2006 Market share analysis
Figure 4.7: 2011 Market share analysis
Figure 4.8: Global market share analysis 2011
Figure 4.9: Global market fragmentation 2011
Figure 4.10: Market value North America (US $B)
Figure 4.11: Market value Europe (US $B)
Figure 4.12: Market value Asia Pacific (US $B)
Figure 4.13: Market value Row: (US $B)
Figure 4.14: Regional revenue evaluation 2011(US $M)
Figure 4.15: Regional revenue evaluation 2011(%)
Figure 4.16: North American revenue trend for top players 2007-2011 (US $B)
Figure 4.17: Europe revenue trend for top players 2007-2011 (US $B)
Figure 4.18: Asia Pacific revenue trend for top players 2007-2011 (US $B)
Figure 4.19: Row revenue trend for top players 2007-2011 (US $B)
Figure 4.20: Lucintel triad - top five major players
CHAPTER 5. Company Profile of Abbott Laboratories
Figure 5.1: Abbott Laboratories revenue by business structure 2011
Figure 5.2: Lucintel Triad – Abbott Laboratories
Figure 5.3: Financial benchmarking Abbott Laboratories against top three and top five industry players’ average
Figure 5.4: Financial benchmarking of Abbott Laboratories against Top Five best
Figure 5.5: Global industry revenue trend Vs Abbott Laboratories (2007-2011) in US $B
Figure 5.6: Global market share trend for Abbott Laboratories (2007-2011) in (%)
Figure 5.7: North American industry revenue trend Vs Abbott Laboratories 2007-2011 in (US $B)
Figure 5.8: European industry revenue trend Vs Abbott Laboratories 2007-2011 in (US $B)
Figure 5.9: APAC industry revenue trend Vs Abbott Laboratories 2007-2011 in (US $B)
Figure 5.10: ROW industry revenue trend Vs Abbott Laboratories 2007-2011 in (US $B)
Figure 5.11: North American market share trend Vs Abbott Laboratories 2007-2011 in (%)
Figure 5.12: European market share trend Vs Abbott Laboratories 2007-2011 in (%)
Figure 5.13: APAC market share trend Vs Abbott Laboratories 2007-2011 in (%)
Figure 5.14: ROW market share trend Vs Abbott Laboratories 2007-2011 in (%)
Figure 5.15: Abbott Laboratories productivity: 2007-2011 in (US $B)
Figure 5.16: Abbott Laboratories fixed asset value: 2007-2011 in (US $B)
Figure 5.17: Strategic execution
CHAPTER 6. Company Profile of Invacare Corporation
Figure 6.1: Invacare Corporation. revenue by business structure 2011
Figure 6.2: Lucintel triad - Invacare Corporation
Figure 6.3: Financial benchmarking of Invacare Corporation. against top three and top five industry players’ average
Figure 6.4: Financial benchmarking of Invacare Corporation against Top five best
Figure 6.5: Global industry revenue trend Vs Invacare Corporation (2007-2011) in (US $B)
Figure 6.6: Global market share trend for Invacare Corporation. (2007-2011) in (%)
Figure 6.7: North American industry revenue trend Vs Invacare Corporation (2007-2011 in (US $B)
Figure 6.8: European industry revenue trend Vs Invacare Corporation 2007-2011 in (US $B)
Figure 6.9: APAC industry revenue trend Vs Invacare Corporation 2007-2011 in (US $B)
Figure 6.10: ROW industry revenue trend Vs Invacare Corporation 2007-2011 in (US $B)
Figure 6.11: North American market share trend Vs Invacare Corporation 2007-2011 in (%)
Figure 6.12: European market share trend Vs Invacare Corporation 2007-2011 in (%)
Figure 6.13: APAC market share trend Vs Invacare Corporation 2007-2011 in (%)
Figure 6.14: ROW market share trend Vs Invacare Corporation 2007-2011 in (%)
Figure 6.15: Invacare Corporation productivity: 2007-2011 in (US $B)
Figure 6.16: Invacare Corporation fixed asset value: 2007-2011 in (US $B)
Figure 6.17: Strategic execution
CHAPTER 7. Company Profile of Johnson & Johnson
Figure 7.1: Johnson & Johnson revenue by business structure 2011
Figure 7.2: Lucintel triad – Johnson & Johnson
Figure 7.3: Financial benchmarking of Johnson & Johnson against top three and top five industry players’ average
Figure 7.4: Financial benchmarking of Johnson & Johnson against Top five best
Figure 7.5: Global industry revenue trend Vs Johnson & Johnson (2007-2011) in (US $B)
Figure 7.6: Global market share trend for Johnson & Johnson (2007-2011) in (%)
Figure 7.7: North American industry revenue trend Vs Johnson & Johnson (2007-2011) in (US $B)
Figure 7.8: European industry revenue trend Vs Johnson & Johnson (2007-2011) in (US $B)
Figure 7.9: APAC industry revenue trend Vs Johnson & Johnson (2007-2011) in (US $B)
Figure 7.10: ROW industry revenue trend Vs Johnson & Johnson (2007-2011) in (US $B)
Figure 7.11: North American market share trend Vs Johnson & Johnson (2007-2011) in (%)
Figure 7.12: European market share trend Vs Johnson & Johnson (2007-2011) in (%)
Figure 7.13: APAC market share trend Vs Johnson & Johnson (2007-2011) in (%)
Figure 7.14: ROW market share trend Vs Johnson & Johnson (2007-2011) in (%)
Figure 7.15: Johnson & Johnson productivity: 2007-2011 in (US $B)
Figure 7.16: Johnson & Johnson fixed asset value: 2007-2011 in (US $B)
Figure 7.17: Strategic execution
CHAPTER 8. Company Profile of 3M
Figure 8.1: 3M revenue by business structure 2011
Figure 8.2: Lucintel triad – 3M
Figure 8.3: Financial benchmarking of 3M against top three and top five industry players’ average
Figure 8.4: Financial benchmarking of3M against Top five best
Figure 8.5: Global industry revenue trend Vs 3M (2007-2011) in (US $B)
Figure 8.6: Global market share trend for3M (2007-2011) in (%)
Figure 8.7: North American industry revenue trend Vs 3M (2007-2011) in (US $B)
Figure 8.8: European industry revenue trend Vs 3M (2007-2011) in (US $B)
Figure 8.9: APAC industry revenue trend Vs 3M (2007-2011) in (US $B)
Figure 8.10: ROW industry revenue trend Vs3M (2007-2011) in (US $B)
Figure 8.11: North American market share trend Vs 3M (2007-2011) in (%)
Figure 8.12: European market share trend Vs 3M (2007-2011) in (%)
Figure 8.13: APAC market share trend Vs 3M. (2007-2011) in (%)
Figure 8.14: ROW market share trend Vs 3M (2007-2011) in (%)
Figure 8.15: 3M productivity: 2007-2011 in (US $B)
Figure 8.16: 3M fixed asset value: 2007-2011 in (US $B)
Figure 8.17: Strategic execution
CHAPTER 9. Company Profile of Philips
Figure 9.1: Philips revenue by business structure 2011
Figure 9.2: Lucintel triad – Philips
Figure 9.3: Financial benchmarking of Philips against top three and top five industry players’ average
Figure 9.4: Financial benchmarking of Philips against Top five best
Figure 9.5: Global industry revenue trend Vs Philips (2007-2011) in (US $B)
Figure 9.6: Global market share trend for Philips (2007-2011) in (%)
Figure 9.7: North American industry revenue trend Vs Philips (2007-2011) in (US $B)
Figure 9.8: European industry revenue trend Vs Philips (2007-2011) in (US $B)
Figure 9.9: APAC industry revenue trend Vs Philips (2007-2011) in (US $B)
Figure 9.10: ROW industry revenue trend Vs Philips (2007-2011) in (US $B)
Figure 9.11: North American market share trend Vs Philips (2007-2011) in (%)
Figure 9.12: European market share trend Vs Philips (2007-2011) in (%)
Figure 9.13: APAC market share trend Vs Philips (2007-2011) in (%)
Figure 9.14: ROW market share trend Vs Philips (2007-2011) in (%)
Figure 9.15: Philips productivity: 2007-2011 in (US $B)
Figure 9.16: Philips fixed asset value: 2006-2010 in (US $B)
Figure 9.17: Strategic execution
LIST OF TABLES
CHAPTER 3. Market Opportunity
Table 3.1: Industry parameters of global pesticide industry
Table 3.2: Relative market attractiveness by region
Table 3.3: Regional revenue growth rate
Table 3.4: Segment revenue growth rate
CHAPTER 4. Competitive Benchmarking (Financial and Market)
Table 4.1: Financial benchmarking of top five global pesticide companies
Table 4.2: Key financial parameters for top five pesticide companies
Table 4.3: Regional Revenue (US $M)
Table 4.4: Regional Revenue (%)
Table 4.5: Competitors based on markets served
Table 4.6: Lucintel triad - Top five major players
CHAPTER 5. Company Profile of Abbott Laboratories
Table 5.1: Market served: Abbott Laboratories
Table 5.2: Lucintel triad – Abbott Laboratories
Table 5.3: Financial Benchmarking of Abbott Laboratories against best and against Top three and Top five industry players’ average
Table 5.4: Strategic execution – product positioning by segment
Table 5.5: Strategic execution – perceived customer value / quality
Table 5.6: Strategic execution – promotion / communications
Table 5.7: Strategic execution – product distribution by region
CHAPTER 6. Company Profile of Invacare Corporation
Table 6.1: Market served – Invacare Corporation.
Table 6.2: Lucintel triad – Invacare Corporation
Table 6.3: Financial benchmarking of Invacare Corporation best and against Top three and Top five industry players’ average
Table 6.4: Strategic execution – product positioning by segment
Table 6.5: Strategic execution – perceived customer value / quality
Table 6.6: Strategic execution – promotion / communications
Table 6.7: Strategic execution – product distribution by region
CHAPTER 7. Company Profile of Johnson & Johnson
Table 7.1: Market served – Johnson & Johnson
Table 7.2: Lucintel triad – Johnson & Johnson
Table 7.3: Financial benchmarking of Johnson & Johnson against best and against Top three and Top five industry players’ average
Table 7.4: Strategic execution – product positioning by segment
Table 7.5: Strategic execution – perceived customer value / quality
Table 7.6: Strategic execution – promotion / communications
Table 7.7: Strategic execution – product distribution by region
CHAPTER 8. Company Profile of 3M
Table 8.1: Market served – 3M
Table 8.2: Lucintel triad – 3M
Table 8.3: Financial Benchmarking of 3M against best and against Top three and top five industry players’ average
Table 8.4: Strategic execution – product positioning by segment
Table 8.5: Strategic execution – perceived customer value / quality
Table 8.6: Strategic execution – promotion / communications
Table 8.7: Strategic execution – product distribution by region
CHAPTER 9. Company Profile of Philips
Table 9.1: Markets Served – Philips
Table 9.2: Lucintel triad – Philips
Table 9.3: Financial Benchmarking of Philips against best and against Top three and top five industry players’ average
Table 9.4: Strategic execution – product positioning by segment
Table 9.5: Strategic execution – perceived customer value / quality
Table 9.6: Strategic execution – promotion / communications
Table 9.7: Strategic execution – product distribution by region
CHAPTER 3. Market Opportunity
Table 3.1: Industry parameters of global pesticide industry
Table 3.2: Relative market attractiveness by region
Table 3.3: Regional revenue growth rate
Table 3.4: Segment revenue growth rate
CHAPTER 4. Competitive Benchmarking (Financial and Market)
Table 4.1: Financial benchmarking of top five global pesticide companies
Table 4.2: Key financial parameters for top five pesticide companies
Table 4.3: Regional Revenue (US $M)
Table 4.4: Regional Revenue (%)
Table 4.5: Competitors based on markets served
Table 4.6: Lucintel triad - Top five major players
CHAPTER 5. Company Profile of Abbott Laboratories
Table 5.1: Market served: Abbott Laboratories
Table 5.2: Lucintel triad – Abbott Laboratories
Table 5.3: Financial Benchmarking of Abbott Laboratories against best and against Top three and Top five industry players’ average
Table 5.4: Strategic execution – product positioning by segment
Table 5.5: Strategic execution – perceived customer value / quality
Table 5.6: Strategic execution – promotion / communications
Table 5.7: Strategic execution – product distribution by region
CHAPTER 6. Company Profile of Invacare Corporation
Table 6.1: Market served – Invacare Corporation.
Table 6.2: Lucintel triad – Invacare Corporation
Table 6.3: Financial benchmarking of Invacare Corporation best and against Top three and Top five industry players’ average
Table 6.4: Strategic execution – product positioning by segment
Table 6.5: Strategic execution – perceived customer value / quality
Table 6.6: Strategic execution – promotion / communications
Table 6.7: Strategic execution – product distribution by region
CHAPTER 7. Company Profile of Johnson & Johnson
Table 7.1: Market served – Johnson & Johnson
Table 7.2: Lucintel triad – Johnson & Johnson
Table 7.3: Financial benchmarking of Johnson & Johnson against best and against Top three and Top five industry players’ average
Table 7.4: Strategic execution – product positioning by segment
Table 7.5: Strategic execution – perceived customer value / quality
Table 7.6: Strategic execution – promotion / communications
Table 7.7: Strategic execution – product distribution by region
CHAPTER 8. Company Profile of 3M
Table 8.1: Market served – 3M
Table 8.2: Lucintel triad – 3M
Table 8.3: Financial Benchmarking of 3M against best and against Top three and top five industry players’ average
Table 8.4: Strategic execution – product positioning by segment
Table 8.5: Strategic execution – perceived customer value / quality
Table 8.6: Strategic execution – promotion / communications
Table 8.7: Strategic execution – product distribution by region
CHAPTER 9. Company Profile of Philips
Table 9.1: Markets Served – Philips
Table 9.2: Lucintel triad – Philips
Table 9.3: Financial Benchmarking of Philips against best and against Top three and top five industry players’ average
Table 9.4: Strategic execution – product positioning by segment
Table 9.5: Strategic execution – perceived customer value / quality
Table 9.6: Strategic execution – promotion / communications
Table 9.7: Strategic execution – product distribution by region
